Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-Line Treatment for Advanced Squamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-Line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer: A Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 Apr 01;[EPub Ahead of Print], J Wang, S Lu, X Yu, Y Hu, Y Sun, Z Wang, J Zhao, Y Yu, C Hu, K Yang, G Feng, K Ying, W Zhuang, J Zhou, J Wu, SJ Leaw, J Zhang, X Lin, L Liang, N YangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.